The Expression of Vascular Endothelial Growth Factor and Its Receptors in Congenital Bronchopulmonary Cystic Malformations

European Journal of Pediatric Surgery, 04/26/2012

The data suggest a possible role of VEGF–VEGFR2 interaction in the pathogenesis of congenital bronchopulmonary cystic malformations. However, VEGFR2 does not represent a suitable histochemical marker to distinguish between Bronchopulmonary sequestration (BPS) and congenital cystic adenomatoid malformation (CCAM).

Print Article Summary Cat 2 CME Report